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We describe the first case of community-acquired bacteremia caused by
Acinetobacter radioresistens; the patient was a 32-year-old HIV-positive
neutropenic woman. Ambiguous Gram staining and poor biochemical reac-
tivity of blood culture isolates misguided early diagnosis and therapy. Bacte-
rial identification was based on 16S rDNA sequence analysis.  A.
radioresistens can be considered as a cause of opportunistic infection in
immunodeficient patients.
Members of the genus Acinetobacter are described as
gram-negative, strictly aerobic diplococcoid rods that are oxi-
dase negative and catalase positive (1). The genus includes
at least 19 genomic species, defined on the basis of DNA
relatedness criteria (2), which are ubiquitous in nature and
have become increasingly responsible for a range of systemic
infections in critically ill and immunocompromised patients
(3). Genospecies 1 (A. calcoaceticus), 2 (A. baumannii), 3, and
13TU, classified as the Acb complex, are prevalent in nosoco-
mial pneumonia and bacteremia but rarely colonize healthy
persons (3,4). Genospecies 8/9 (A. lwoffii), 15BJ, and 12 (A.
radioresistens) constitute part of the normal skin microflora
but are seldom associated with human infections (5).
Acinetobacter spp. are responsible for 1%-2% of nosoco-
mial bloodstream infections (4,6), in which A. baumannii
represents the most commonly isolated species (3,7). Few
Acinetobacter bacteremias are community acquired (8). The
respiratory system and vascular devices are the main portals
for entry of Acinetobacter into the bloodstream of critically ill
persons (9). Secondary bloodstream invasion, resulting from
dissemination of the bacterium from covert colonization
sites, can also be considered when evidence of primary infec-
tion is missing (10). The outcome of Acinetobacter bacteremia
is usually benign, with the prognosis depending on the sever-
ity of underlying disease(s) and the efficacy of antibiotic
therapy (7-10).
In most clinical microbiology laboratories, identification
of Acinetobacter cannot routinely be achieved at the genospe-
cies level because commercial identification systems are sub-
stantially deficient and poorly discriminatory in
distinguishing these organisms. This implies that local data
on the prevalence of individual species in human infections
should be interpreted cautiously unless supported by DNA-
based taxonomy. Here we report a case of community-
acquired  A. radioresistens bacteremia in an HIV-positive
patient, in which the causative agent was identified by
means of 16S ribosomal DNA (rDNA) sequencing.
 The Study
In January 2000, a 32-year-old HIV-positive woman was
admitted to the National Institute for Infectious Diseases “L.
Spallanzani,” Rome, with a 10-day history of fever, produc-
tive cough, headache, rhinitis, and muscular pain. She
tested HIV positive in 1993, citing heterosexual risk factors.
In December 1999, she had HIV viremia of <80 copies/mL
and a CD4+ cell count of 309/mm3. She had never taken anti-
retroviral therapy and had not been on antibiotic treatment
in the previous 6 months.
The patient’s recent history included chronic left suppu-
rative otitis media with ear drainage and recurrent attacks
of headache. One week before admission she had undergone
computerized tomography scans of the brain, with contrast
infusion; the scans were normal. 
On admission the patient had fever (37.8°C), pallor,
headache, left ear pain, and hearing loss. Lung examination
revealed sparse crackles, but the chest radiograph was nor-
mal. Laboratory values were significant for leukopenia, with
a leukocyte count of 2.5x103/mm3 (normal range 4.3-
10.8x103/mm3), and neutropenia (1.0x103/mm3; normal
range 1.4-7.5x103/mm3). C-reactive protein (CRP) was 2.1
mg/L (normal values <6 mg/L), erythrocyte sedimentation
rate (ESR) 66 mm in the first hour (normal values <15 mm
per hour), and platelet count 118x103/mm3 (normal range
140-440/mm3). The urine was normal, as were electrolytes,
glucose, hemoglobin, and creatinine. X-ray examination of
the sinuses revealed thickening of the right mucous mem-
branes. Otoscopy revealed chronic left middle ear disease
with acute inflammation. Two blood cultures, taken 3 and 6
hours after admission, were negative.
After 2 days in hospital, the patient returned home
against the advice of the physicians. At home she was fever-
ish and had continuous headache and reoccurence of left ear
pain. One week later she was readmitted with fever (39.1°C),
leukopenia (2.5x103/mm3), neutropenia (0.7x103/mm3),
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higher CRP levels (3.2 mg/L), and accelerated ESR (70 mm
per hour). Physical examination showed no substantial
changes compared with one week earlier. Because of the
patient’s symptoms and the results of otoscopy, a diagnosis
of chronic middle ear disease was made, and she was treated
empirically with intravenous ceftriaxone (2 g once a day) and
gentamicin (80 mg three times a day).
Three days later, five of six blood cultures taken at 3-
hour intervals during the first day of her second admission
yielded visible bacterial growth. Gram staining of blood-free
supernatants from all positive cultures was interpreted as
showing a homogeneous smear of gram-positive diplococci
and was used as the inoculum of Sceptor gram-positive
Breakpoint/ID panels (Becton Dickinson, Franklin Lakes,
NJ). Individual isolates from all five positive blood cultures
showed an identical antibiotic-susceptibility pattern; they
were resistant to penicillin, oxacillin, amoxicillin/clavulan-
ate, clarithromycin, clindamycin, chloramphenicol, erythro-
mycin, vancomycin, and teicoplanin, but sensitive to
aminoglycosides, carbapenems, cephalosporins, ciprofloxa-
cin, cotrimoxazole, and tetracycline. Bacterial identification-
could not be achieved because of lack of biochemical
reactivity of the strain. Previous antibiotic therapy was dis-
continued, and intravenous ciprofloxacin (400 mg twice a
day) was begun for 2 weeks.
All blood culture isolates grew vigorously at 37°C on
both chocolate agar and Columbia agar base supplemented
with 5% (vol/vol) sheep blood, giving similarly smooth,
opaque, nonhemolytic colonies. Tiny colonies appeared on
eosin-methylene blue (EMB)-lactose agar after 36-48 hours’
incubation. The presence of gram-positive coccobacillary
forms, mostly organized in pairs, was confirmed for primary
isolates. Growth was not detected on either mannitol salt
agar or D-coccosel agar or, under anaerobic conditions, on
Columbia agar base. Catalase and oxidase reactions were
positive and negative, respectively. Infection by Alloiococcus
otitidis was initially suspected, but specific biochemical tests
and antibiotic susceptibility data argued against this
hypothesis (data not shown).
Bacterial identification was achieved by means of 16S
ribosomal DNA (rDNA) sequence analysis. Genomic DNA
was extracted from each of the five isolates with a commer-
cial kit (Quiagen genomic-tip, Qiagen Inc., Valencia, CA),
and polymerase chain reaction (PCR) amplification was per-
formed with universal primers annealing at the extreme 5'
and 3' ends of the eubacterial 16S rDNA  (encompassing
nucleotides 9-27 and 1492-1512 relative to the Escherichia
coli 16S rDNA sequence, International Union for Biochemis-
try [IUB] nomenclature) (2). The 16S rDNA amplicon was
purified with the QUAquick PCR purification kit (Qiagen)
and partially sequenced on one strand from the 5'-end using
an ABI PRISM 377 (PE Applied Biosystems, Foster City,
CA) automated sequencer and dye-labeled dideoxy chain-ter-
minator chemistry (Dye Terminator Cycle sequencing Ready
Reaction Kit, Applied Biosystems Inc.). Identical partial
sequences were obtained for all the five amplicons analyzed,
corresponding approximately to nucleotides 60-500 of the
E.coli 16S rDNA gene sequence. Comparative BLAST soft-
ware (version 2.0, National Center for Biotechnology Insti-
tute, http://www.ncbi.nlm.nih.gov/BLAST/) analysis with
entries available at the EMBL, GenBank, and Ribosomal
Data Project (http://www.cme.msu.edu/RDP/) databases
retrieved an optimum alignment (99.4% identity) with the
16S rDNA of the A. radioresistens type strain M17694 (Gen-
Bank sequence accession number Z93445; ref. 2), and an
excellent match with the published  A. radioresistens 16S
rDNA signature regions (Table). The sequence within the
hypervariable helix 6 showed a G/A mismatch at position 75,
compared with the published A. radioresistens sequence (2).
However, the same single-base difference was found in the
corresponding 16S rDNA signature of the partial sequence
recently deposited under the accession number AJ247210,
corresponding to A. radioresistens LMG 10614 (Harmsen D,
Singer C, unpub. data).
Biochemical identification was repeated with the Scep-
tor gram-negative Breakpoint/ID and API 20NE panels.
Both systems misidentified the organism as A. lwoffi (Scep-
tor and API codes were 0000000 and 0000032, respectively),
although the combined results of both biochemical and
assimilation tests were compatible with the identification as
A. radioresistens.
Ten days after beginning the course of ciprofloxacin, the
patient improved symptomatically, her temperature sub-
sided, and serologic markers of inflammation declined (CRP
and ESR values were 0.9 mg/L and 25 mm, respectively).
She was discharged from hospital 4 days later, and she had
no recrudescence of otitis or bacteremia in a 3-month follow-
up period.
Possible sources of contamination were retrospectively
investigated and ruled out. Infection control procedures in
the unit were reviewed, and sterility control of 24 randomly
sampled blood culture bottles from the same batch gave neg-
ative results. Moreover, no other strains similar to
A.radioresistens were isolated in our institute from Novem-
ber 1999 to March 2000.
Conclusions
To our knowledge, this is the first description of
A.radioresistens causing community-acquired bacteremia.
We speculate that systemic disease developed in our patient
as a result of local infection; the combination of neutropenia
and her impaired immunologic condition due to HIV infec-
tion made her susceptible to the infection.
Paranasal sinuses and the middle ear are potential res-
ervoirs from which bacteria, including Acinetobacter spp.,
can enter the bloodstream; otitis media and sinusitis often
precede bacteremia in predisposed patients (11 and refer-
ences therein). Thus, we speculate that the left middle ear
was the most likely portal for the entry of A. radioresistens
into the bloodstream of the patient, although other sites can-
not be ruled out. The history of recurrent episodes of ear
drainage and the rapid remission of signs and symptoms fol-
lowing targeted antimicrobial therapy point to the middle
ear infection as a plausible source for the systemic spread of
A. radioresistens. Unfortunately, no clinical specimen was
obtained for culture from the middle ear of the patient to
confirm the diagnosis.
A Gram stain of bacteria from positive blood cultures is
considered to be an important guide for the etiologic diagno-
sis and initial antibiotic choice. However, Acinetobacter spp.
are known for being extremely resistant to decolorization (1),
and diagnostic errors due to misinterpretation of well-pre-
pared Gram stains have been reported (12). In our case, the
gram-positive appearance of primary cultures ofDispatches
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A.radioresistens delayed bacterial identification, and it was
not until the organism was later observed growing on EMB
agar that an incorrect diagnosis was suspected. Cases of A.
radioresistens infection may be underestimated because this
species escapes routine detection by most commercially
available microbiologic tests ( A. radioresistens is not
included in the Sceptor version 3.10 database and in the API
20NE analytic catalog, 6th edition, 1998). Bacterial identifi-
cation based on 16S rDNA sequence analysis can be per-
formed directly on monomicrobic blood cultures and can be
completed within 36 hours at relatively low cost. This case
highlights the power of this technique for the rapid and cor-
rect identification of A. radioresistens.
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